(KEY) KeyCorp - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4932671088
Stock: Loans, Deposits, Investments, Wealth Management, Advisory
Total Rating 32
Risk 29
Buy Signal -0.60
| Risk 5d forecast | |
|---|---|
| Volatility | 33.1% |
| Relative Tail Risk | -7.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 0.15 |
| Character TTM | |
|---|---|
| Beta | 1.404 |
| Beta Downside | 1.482 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.21% |
| CAGR/Max DD | 0.65 |
EPS (Earnings per Share)
Revenue
Description: KEY KeyCorp March 05, 2026
KeyCorp is a bank holding company for KeyBank National Association, operating in the United States. Its operations are divided into Consumer Bank and Commercial Bank segments.
The Consumer Bank segment offers deposit and investment products, personal finance services, various lending options including mortgages and student loan refinancing, and wealth management. This segment targets individual consumers and high-net-worth clients.
The Commercial Bank segment provides lending, cash management, equipment financing, and commercial mortgage loans. It also delivers capital market products and services, such as syndicated finance, debt and equity underwriting, and M&A advisory, to large corporate and institutional clients. Regional banks typically focus on a specific geographic area, allowing for tailored services and strong local relationships.
KeyCorp also offers trust and custody services, international banking, community development financing, and investment banking. The banking sector is highly regulated, impacting capital requirements and operational procedures. Further research on ValueRay can provide in-depth financial metrics and analyst ratings for KeyCorp.
Headlines to watch out for
- Net interest income sensitive to Federal Reserve rate policy
- Loan growth in commercial and consumer segments drives revenue
- Non-interest income from capital markets impacts profitability
- Regulatory compliance costs influence operational expenses
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 1.83b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.82 > 1.0 |
| NWC/Revenue: -316.2% < 20% (prev -1.40k%; Δ 1.08k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 2.21b > Net Income 1.83b |
| Net Debt (9.71b) to EBITDA (2.32b): 4.18 < 3 |
| Current Ratio: 0.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.10b) vs 12m ago 10.98% < -2% |
| Gross Margin: 62.27% > 18% (prev 0.45%; Δ 6.18k% > 0.5%) |
| Asset Turnover: 6.02% > 50% (prev 4.84%; Δ 1.18% > 0%) |
| Interest Coverage Ratio: 0.44 > 6 (EBITDA TTM 2.32b / Interest Expense TTM 3.75b) |
Altman Z'' -0.83
| A: -0.19 (Total Current Assets 118.70b - Total Current Liabilities 154.08b) / Total Assets 184.38b |
| B: 0.08 (Retained Earnings 15.36b / Total Assets 184.38b) |
| C: 0.01 (EBIT TTM 1.66b / Avg Total Assets 185.77b) |
| D: 0.09 (Book Value of Equity 14.66b / Total Liabilities 164.00b) |
| Altman-Z'' Score: -0.83 = CCC |
Beneish M 1.00
| DSRI: 31.40 (Receivables 105.11b/2.71b, Revenue 11.19b/9.05b) |
| GMI: 0.72 (GM 62.27% / 44.82%) |
| AQI: 0.41 (AQ_t 0.35 / AQ_t-1 0.86) |
| SGI: 1.24 (Revenue 11.19b / 9.05b) |
| TATA: -0.00 (NI 1.83b - CFO 2.21b) / TA 184.38b) |
| Beneish M-Score: 21.56 (Cap -4..+1) = D |
What is the price of KEY shares?
As of March 19, 2026, the stock is trading at USD 19.10 with a total of 16,113,527 shares traded.
Over the past week, the price has changed by -2.95%, over one month by -12.22%, over three months by -8.03% and over the past year by +25.84%.
Over the past week, the price has changed by -2.95%, over one month by -12.22%, over three months by -8.03% and over the past year by +25.84%.
Is KEY a buy, sell or hold?
KeyCorp has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy KEY.
- StrongBuy: 8
- Buy: 5
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KEY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.6 | 28.5% |
| Analysts Target Price | 24.6 | 28.5% |
KEY Fundamental Data Overview March 16, 2026
P/E Trailing = 12.4342
P/E Forward = 10.6157
P/S = 2.9391
P/B = 1.1517
P/EG = 1.7997
Revenue TTM = 11.19b USD
EBIT TTM = 1.66b USD
EBITDA TTM = 2.32b USD
Long Term Debt = 9.92b USD (from longTermDebt, last quarter)
Short Term Debt = 1.08b USD (from shortTermDebt, last quarter)
Debt = 11.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.71b USD (from netDebt column, last quarter)
Enterprise Value = 20.15b USD (20.59b + Debt 11.00b - CCE 11.45b)
Interest Coverage Ratio = 0.44 (Ebit TTM 1.66b / Interest Expense TTM 3.75b)
EV/FCF = 9.59x (Enterprise Value 20.15b / FCF TTM 2.10b)
FCF Yield = 10.43% (FCF TTM 2.10b / Enterprise Value 20.15b)
FCF Margin = 18.78% (FCF TTM 2.10b / Revenue TTM 11.19b)
Net Margin = 16.35% (Net Income TTM 1.83b / Revenue TTM 11.19b)
Gross Margin = 62.27% ((Revenue TTM 11.19b - Cost of Revenue TTM 4.22b) / Revenue TTM)
Gross Margin QoQ = 66.05% (prev 62.80%)
Tobins Q-Ratio = 0.11 (Enterprise Value 20.15b / Total Assets 184.38b)
Interest Expense / Debt = 7.84% (Interest Expense 863.0m / Debt 11.00b)
Taxrate = 21.30% (138.0m / 648.0m)
NOPAT = 1.30b (EBIT 1.66b * (1 - 21.30%))
Current Ratio = 0.77 (Total Current Assets 118.70b / Total Current Liabilities 154.08b)
Debt / Equity = 0.54 (Debt 11.00b / totalStockholderEquity, last quarter 20.38b)
Debt / EBITDA = 4.18 (Net Debt 9.71b / EBITDA 2.32b)
Debt / FCF = 4.62 (Net Debt 9.71b / FCF TTM 2.10b)
Total Stockholder Equity = 19.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.98% (Net Income 1.83b / Total Assets 184.38b)
RoE = 9.26% (Net Income TTM 1.83b / Total Stockholder Equity 19.74b)
RoCE = 5.58% (EBIT 1.66b / Capital Employed (Equity 19.74b + L.T.Debt 9.92b))
RoIC = 4.28% (NOPAT 1.30b / Invested Capital 30.44b)
WACC = 9.38% (E(20.59b)/V(31.60b) * Re(11.09%) + D(11.00b)/V(31.60b) * Rd(7.84%) * (1-Tc(0.21)))
Discount Rate = 11.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.28%
[DCF] Terminal Value 64.41% ; FCFF base≈1.50b ; Y1≈990.9m ; Y5≈457.8m
[DCF] Fair Price = N/A (negative equity: EV 7.21b - Net Debt 9.71b = -2.50b; debt exceeds intrinsic value)
EPS Correlation: -24.50 | EPS CAGR: -2.45% | SUE: 0.12 | # QB: 0
Revenue Correlation: 68.69 | Revenue CAGR: 15.06% | SUE: 3.24 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.44 | Chg7d=+0.000 | Chg30d=-0.001 | Revisions Net=+1 | Analysts=15
EPS current Year (2026-12-31): EPS=1.80 | Chg7d=+0.000 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=+20.3% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=2.12 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+5 | Growth EPS=+17.7% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: +0.14 (4 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.0% (Discount Rate 11.1% - Earnings Yield 8.0%)
[Growth] Growth Spread = +4.9% (Analyst 7.9% - Implied 3.0%)
P/E Forward = 10.6157
P/S = 2.9391
P/B = 1.1517
P/EG = 1.7997
Revenue TTM = 11.19b USD
EBIT TTM = 1.66b USD
EBITDA TTM = 2.32b USD
Long Term Debt = 9.92b USD (from longTermDebt, last quarter)
Short Term Debt = 1.08b USD (from shortTermDebt, last quarter)
Debt = 11.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.71b USD (from netDebt column, last quarter)
Enterprise Value = 20.15b USD (20.59b + Debt 11.00b - CCE 11.45b)
Interest Coverage Ratio = 0.44 (Ebit TTM 1.66b / Interest Expense TTM 3.75b)
EV/FCF = 9.59x (Enterprise Value 20.15b / FCF TTM 2.10b)
FCF Yield = 10.43% (FCF TTM 2.10b / Enterprise Value 20.15b)
FCF Margin = 18.78% (FCF TTM 2.10b / Revenue TTM 11.19b)
Net Margin = 16.35% (Net Income TTM 1.83b / Revenue TTM 11.19b)
Gross Margin = 62.27% ((Revenue TTM 11.19b - Cost of Revenue TTM 4.22b) / Revenue TTM)
Gross Margin QoQ = 66.05% (prev 62.80%)
Tobins Q-Ratio = 0.11 (Enterprise Value 20.15b / Total Assets 184.38b)
Interest Expense / Debt = 7.84% (Interest Expense 863.0m / Debt 11.00b)
Taxrate = 21.30% (138.0m / 648.0m)
NOPAT = 1.30b (EBIT 1.66b * (1 - 21.30%))
Current Ratio = 0.77 (Total Current Assets 118.70b / Total Current Liabilities 154.08b)
Debt / Equity = 0.54 (Debt 11.00b / totalStockholderEquity, last quarter 20.38b)
Debt / EBITDA = 4.18 (Net Debt 9.71b / EBITDA 2.32b)
Debt / FCF = 4.62 (Net Debt 9.71b / FCF TTM 2.10b)
Total Stockholder Equity = 19.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.98% (Net Income 1.83b / Total Assets 184.38b)
RoE = 9.26% (Net Income TTM 1.83b / Total Stockholder Equity 19.74b)
RoCE = 5.58% (EBIT 1.66b / Capital Employed (Equity 19.74b + L.T.Debt 9.92b))
RoIC = 4.28% (NOPAT 1.30b / Invested Capital 30.44b)
WACC = 9.38% (E(20.59b)/V(31.60b) * Re(11.09%) + D(11.00b)/V(31.60b) * Rd(7.84%) * (1-Tc(0.21)))
Discount Rate = 11.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.28%
[DCF] Terminal Value 64.41% ; FCFF base≈1.50b ; Y1≈990.9m ; Y5≈457.8m
[DCF] Fair Price = N/A (negative equity: EV 7.21b - Net Debt 9.71b = -2.50b; debt exceeds intrinsic value)
EPS Correlation: -24.50 | EPS CAGR: -2.45% | SUE: 0.12 | # QB: 0
Revenue Correlation: 68.69 | Revenue CAGR: 15.06% | SUE: 3.24 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.44 | Chg7d=+0.000 | Chg30d=-0.001 | Revisions Net=+1 | Analysts=15
EPS current Year (2026-12-31): EPS=1.80 | Chg7d=+0.000 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=+20.3% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=2.12 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+5 | Growth EPS=+17.7% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: +0.14 (4 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.0% (Discount Rate 11.1% - Earnings Yield 8.0%)
[Growth] Growth Spread = +4.9% (Analyst 7.9% - Implied 3.0%)